A health adviser for Médecins Sans Frontières said Wednesday that an Ebola outbreak in the Democratic Republic of Congo could become very serious.
The crisis is driven by a rare strain of the virus that spreads quickly and currently lacks an approved vaccine. This combination of rapid transmission and limited medical countermeasures increases the risk of a large-scale epidemic in eastern DRC.
John Johnson, a vaccination and epidemic response adviser for MSF, said, "This could be a very bad outbreak." Johnson is scheduled to fly to the DRC on Thursday to assist with the response [1].
Health officials have reported varying figures regarding the scale of the crisis. France 24 reported more than 130 deaths [1] and more than 500 suspected cases [1]. Other reports from the Associated Press cite 134 deaths [5], while The New York Times reported more than 100 [6]. Earlier reports from CBS News listed at least 80 deaths [3] and more than 250 suspected cases [3].
The response was initially hindered by diagnostic errors. Johnson said tests had initially targeted a more common Ebola strain, which delayed the implementation of an appropriate response [1].
World Health Organization officials have expressed alarm over the current trajectory of the virus. "We are very concerned about the scale and speed of this outbreak," WHO Director-General Dr. Tedros Adhanom Ghebreyesus said [2].
Medical experts emphasize the danger posed by the specific variant of the virus. Dr. Peter Hotez, an infectious-disease expert, said, "The virus is a rare strain for which there is currently no approved vaccine" [7].
“"This could be a very bad outbreak,"”
The identification of a rare Ebola strain complicates the public health response because existing vaccines and protocols designed for common strains are ineffective. The delay in accurate diagnosis, combined with the high speed of transmission in eastern DRC, creates a window of vulnerability where the virus can spread unchecked before specialized containment measures are fully deployed.
